May-31-23 11:30AM |
Why Is Vertex (VRTX) Down 6% Since Last Earnings Report?Zacks Investment Research |
10:05AM |
Got $1,000? 2 Amazing Growth Stocks That Could Help You Retire RicherThe Motley Fool |
May-31-23 07:45AM |
CRISPR Therapeutics: A Galaxy's Worth of Deep ValueThe Motley Fool |
06:20AM |
Should You Invest in the VanEck Biotech ETF (BBH)?Zacks Investment Research |
May-30-23 01:01AM |
Expert Ratings for Vertex PharmaceuticalsBenzinga |
11:00AM |
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023Benzinga |
May-04-23 10:38AM |
1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in MayThe Motley Fool |
05:32AM |
2 Potentially Explosive Stocks to Buy in MayThe Motley Fool |
May-04-23 05:30AM |
3 Top Healthcare Stocks to Buy in MayThe Motley Fool |
May-03-23 10:15AM |
Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals StockThe Motley Fool |
06:20AM |
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?Zacks Investment Research |
May-03-23 05:50AM |
7 Reasons to Buy Vertex Pharmaceuticals Stock NowThe Motley Fool |
May-02-23 05:01AM |
Analyst Expectations for Vertex Pharmaceuticals's FutureBenzinga |
02:00AM |
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?The Motley Fool |
May-02-23 01:00AM |
Baird Maintains Neutral Rating for Vertex Pharmaceuticals: Here's What You Need To KnowBenzinga |
12:49PM |
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?Zacks Investment Research |
May-02-23 12:06PM |
Vertex (VRTX) Q1 Earnings Top Estimates, Revenues Up Y/YZacks Investment Research |
10:00AM |
2 Supercharged Stocks to Buy for 2023 and Hold for at Least 10 YearsThe Motley Fool |
May-02-23 09:09AM |
2 Incredible Growth Stocks That Could Turn $20,000 Into $100,000 by 2030The Motley Fool |
05:50AM |
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVieThe Motley Fool |
May-01-23 09:30AM |
Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call TranscriptThe Motley Fool |
11:00AM |
ImmunoGen (IMGN) Q1 Earnings Beat, Elahere Uptake EncouragingZacks Investment Research |
May-01-23 05:50AM |
The Best Stocks to Invest $5,000 in Right NowThe Motley Fool |
Apr-28-23 03:28AM |
Strength Seen in Vertex (VRTX): Can Its 5.0% Jump Turn into More Strength?Zacks Investment Research |
Apr-27-23 10:23AM |
2 Growth Stocks That Could Double in 5 YearsThe Motley Fool |
03:30AM |
Cytek Biosciences, Inc. (CTKB) Soars 13.4%: Is Further Upside Left in the Stock?Zacks Investment Research |
Apr-25-23 05:45AM |
Vertex Pharmaceuticals (VRTX) Stock Moves -0.27%: What You Should KnowZacks Investment Research |
10:01AM |
Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research |
Apr-25-23 09:45AM |
This Supercharged Dividend King Stock Might Soon Run Out of SteamThe Motley Fool |
Apr-24-23 05:50AM |
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research |
02:00AM |
3 Healthcare Stocks That Could Help Make You a FortuneThe Motley Fool |
Apr-24-23 01:49AM |
With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023Benzinga |
10:00AM |
Earnings Preview: Vertex Pharmaceuticals (VRTX) Q1 Earnings Expected to DeclineZacks Investment Research |
Apr-24-23 07:10AM |
The Zacks Analyst Blog Highlights Linde, Vertex Pharmaceuticals, Edwards Lifesciences, General Motors and MSCIZacks Investment Research |
Apr-21-23 04:20AM |
Top Stock Reports for Linde, Vertex Pharmaceuticals & Edwards LifesciencesZacks Investment Research |
09:49AM |
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?Zacks Investment Research |
Apr-21-23 07:59AM |
Berkshire Hathaway, Gilead Sciences, Vertex Pharmaceuticals And A Break-Out Casino Stock Feature On CNBC's 'Final Trades'Benzinga |
Apr-20-23 02:00AM |
Better Big Biotech Buy: Biogen vs. VertexThe Motley Fool |
10:15AM |
Have $1,000? 2 Explosive Growth Stocks to Buy and Hold No Matter What the Market Does NextThe Motley Fool |
Apr-17-23 05:56AM |
Which Stocks Pass Warren Buffett's $10,000 Test?The Motley Fool |
05:50AM |
Prediction: These Will Be 3 of the Biggest Monster Stocks of the DecadeThe Motley Fool |
Apr-14-23 10:23AM |
Is CRISPR Therapeutics Stock a Buy Now?The Motley Fool |
Apr-13-23 10:15AM |
2 Nasdaq Growth Stocks That Are Screaming Buys in AprilThe Motley Fool |
08:34AM |
Moderna, ConocoPhillips, Vertex Pharmaceuticals And This ETF: CNBC's 'Final Trades'Benzinga |
Apr-12-23 05:50AM |
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should KnowZacks Investment Research |
05:30AM |
Could This Move Make Vertex's Next Blockbuster Even Bigger?The Motley Fool |
Apr-10-23 05:54AM |
My 5 Top Stocks to Buy in AprilThe Motley Fool |
Apr-07-23 10:15AM |
2 Once-in-a-Decade Buying Opportunities in a Growth Stock Bear MarketThe Motley Fool |
05:41AM |
A Bull Market Is Coming: 2 Unstoppable Growth Stocks to Scoop Up Right NowThe Motley Fool |
Apr-06-23 09:37AM |
2 Smartest Growth Stocks to Buy Without Hesitation Right NowThe Motley Fool |